Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis
Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-sta...
Saved in:
Cover
Loading…
| Abstract | Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.
From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.
Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.
LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. |
|---|---|
| AbstractList | Background. Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. Methods. From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores. Results. Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. Conclusions. LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients. From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores. Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation. LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.BACKGROUNDCritical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.METHODSFrom February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.RESULTSTwo of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.CONCLUSIONSLT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. BackgroundCritical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.MethodsFrom February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.ResultsTwo of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.ConclusionsLT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. |
| Abstract_FL | Background::Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.Methods::From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.Results::Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.Conclusions::LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained. |
| Author | Huang, Jian-An Lu, Xiao-Jie Xu, Xin Jiang, Shu-Yun Zhao, Jin Li, Jia-Shu Jiao, Guo-Hui Wang, Da-Peng Huang, Dong-Xiao Liu, Feng Lu, Rong-Guo Zhang, Xiao-Qin He, Jian-Xing Huang, Jian Zhou, Li Wu, Bo Wang, Gui-Long Jiao, Guo-Qing Wei, Dong Qiao, Kun Ye, Shu-Gao Chen, Jing-Yu Hu, Chun-Xiao Li, Hui-Xing Yang, Yi |
| AuthorAffiliation | Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China Department of Respiratory Medicine and Critical Care Medicine, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China Department of Cardiothoracic Surgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China Department of Thoracic Surgery/Oncology, State Key Labora |
| AuthorAffiliation_xml | – name: Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China – name: Department of Respiratory Medicine and Critical Care Medicine, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China – name: Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China – name: Department of Cardiothoracic Surgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: Department of Thoracic Surgery, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518100, China – name: Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China – name: Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China – name: Wuxi Lung Transplant Center, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Thoracic Surgery, Shenzhen Third People’s Hospital, Shenzhen, Guangdong 518100, China%Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China%Department of Cardiothoracic Surgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China%Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China%Department of Respiratory Medicine and Critical Care Medicine, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China%Department of Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Anesthesiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China – name: 4 Department of Cardiothoracic Surgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: 2 Department of Thoracic Surgery, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518100, China – name: 10 Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China – name: 1 Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: 3 Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China – name: 5 Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China – name: 6 Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China – name: 8 Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – name: 7 Department of Respiratory Medicine and Critical Care Medicine, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China – name: 9 Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China |
| Author_FL | Yang Yi Hu Chun-Xiao Jiang Shu-Yun Wei Dong Ye Shu-Gao Wang Gui-Long Zhang Xiao-Qin Li Hui-Xing Wang Da-Peng Xu Xin Jiao Guo-Qing Liu Feng Huang Dong-Xiao Li Jia-Shu Jiao Guo-Hui Zhao Jin Huang Jian Huang Jian-An Lu Rong-Guo Wu Bo Zhou Li Qiao Kun Chen Jing-Yu Lu Xiao-Jie He Jian-Xing |
| Author_FL_xml | – sequence: 1 fullname: Chen Jing-Yu – sequence: 2 fullname: Qiao Kun – sequence: 3 fullname: Liu Feng – sequence: 4 fullname: Wu Bo – sequence: 5 fullname: Xu Xin – sequence: 6 fullname: Jiao Guo-Qing – sequence: 7 fullname: Lu Rong-Guo – sequence: 8 fullname: Li Hui-Xing – sequence: 9 fullname: Zhao Jin – sequence: 10 fullname: Huang Jian – sequence: 11 fullname: Yang Yi – sequence: 12 fullname: Lu Xiao-Jie – sequence: 13 fullname: Li Jia-Shu – sequence: 14 fullname: Jiang Shu-Yun – sequence: 15 fullname: Wang Da-Peng – sequence: 16 fullname: Hu Chun-Xiao – sequence: 17 fullname: Wang Gui-Long – sequence: 18 fullname: Huang Dong-Xiao – sequence: 19 fullname: Jiao Guo-Hui – sequence: 20 fullname: Wei Dong – sequence: 21 fullname: Ye Shu-Gao – sequence: 22 fullname: Huang Jian-An – sequence: 23 fullname: Zhou Li – sequence: 24 fullname: Zhang Xiao-Qin – sequence: 25 fullname: He Jian-Xing |
| Author_xml | – sequence: 1 givenname: Jing-Yu surname: Chen fullname: Chen, Jing-Yu organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 2 givenname: Kun surname: Qiao fullname: Qiao, Kun organization: Department of Thoracic Surgery, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518100, China – sequence: 3 givenname: Feng surname: Liu fullname: Liu, Feng organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 4 givenname: Bo surname: Wu fullname: Wu, Bo organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 5 givenname: Xin surname: Xu fullname: Xu, Xin organization: Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China – sequence: 6 givenname: Guo-Qing surname: Jiao fullname: Jiao, Guo-Qing organization: Department of Cardiothoracic Surgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 7 givenname: Rong-Guo surname: Lu fullname: Lu, Rong-Guo organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 8 givenname: Hui-Xing surname: Li fullname: Li, Hui-Xing organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 9 givenname: Jin surname: Zhao fullname: Zhao, Jin organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 10 givenname: Jian surname: Huang fullname: Huang, Jian organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 11 givenname: Yi surname: Yang fullname: Yang, Yi organization: Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China – sequence: 12 givenname: Xiao-Jie surname: Lu fullname: Lu, Xiao-Jie organization: Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China – sequence: 13 givenname: Jia-Shu surname: Li fullname: Li, Jia-Shu organization: Department of Respiratory Medicine and Critical Care Medicine, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China – sequence: 14 givenname: Shu-Yun surname: Jiang fullname: Jiang, Shu-Yun organization: Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 15 givenname: Da-Peng surname: Wang fullname: Wang, Da-Peng organization: Department of Critical Care Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 16 givenname: Chun-Xiao surname: Hu fullname: Hu, Chun-Xiao organization: Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 17 givenname: Gui-Long surname: Wang fullname: Wang, Gui-Long organization: Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 18 givenname: Dong-Xiao surname: Huang fullname: Huang, Dong-Xiao organization: Department of Anesthesiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 19 givenname: Guo-Hui surname: Jiao fullname: Jiao, Guo-Hui organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 20 givenname: Dong surname: Wei fullname: Wei, Dong organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 21 givenname: Shu-Gao surname: Ye fullname: Ye, Shu-Gao organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 22 givenname: Jian-An surname: Huang fullname: Huang, Jian-An organization: Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China – sequence: 23 givenname: Li surname: Zhou fullname: Zhou, Li organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 24 givenname: Xiao-Qin surname: Zhang fullname: Zhang, Xiao-Qin organization: Wuxi Lung Transplant Center, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China – sequence: 25 givenname: Jian-Xing surname: He fullname: He, Jian-Xing organization: Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32251003$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstu1DAUhiNURKeFN0AoEhJik-JbnJhFJVRxqVTEBtaWxzme8ZCxg520Km_AW3PSGap2NkRKrNjf-c_F_0lxFGKAonhJyRklqnl38VWdkYdPy9WTYsFqwapaCnpULAiXspJKqePiJOcNIayuG_msOOaM1ZQQvij-XE1hVY7JhDz0Joxm9DGUJpfjGpIZYBq9LeNwt-vxwE4jlAny4JMZY7otO59H_M9lvg1dilsoXUyljSkGc-3TlGcCTIaSEaqqBL0ZoSuHqd8igQLOL1PMPj8vnjrTZ3ixX0-LH58-fr_4Ul19-3x58eGqslJga0sgHOpOOCmNbVETe1lSJh0XHW06RxXUNTOCUOmWHIAbUTdsqTprXQct4afF5U63i2ajh-S3WIWOxuu7jZhW2iTsugetOqiZVZI66oR1pqXWNZwKBtapls5a5zutYVpuobMQcJL9I9HHJ8Gv9Spe64ZzxblEgTc7gRsTnAkrvYlTCti-_r222w0j2CB-FIJv95lS_DVBHvXWZws93hnEKWvG24bVvBENoq8P0HtRJlqCeUUjkHr1sPT7mv9ZAwGxAyxeT07g7hFK9OxAjQ7Uhw7EsPcHYdbvXIUD8P3_gvc5b2I_Qso_--kGkl6D6cf1jOMkOKnmsRCJbzUHMv4XllDxfA |
| CitedBy_id | crossref_primary_10_35772_ghm_2020_01025 crossref_primary_10_1111_aor_14110 crossref_primary_10_1146_annurev_med_042220_014817 crossref_primary_10_4103_ijn_IJN_453_20 crossref_primary_10_1097_MAT_0000000000001422 crossref_primary_10_2174_1381612829666230717121632 crossref_primary_10_3390_cells10030611 crossref_primary_10_1053_j_jvca_2021_09_013 crossref_primary_10_1016_j_jinf_2020_11_006 crossref_primary_10_1038_s41598_024_65447_w crossref_primary_10_3390_jcm13195922 crossref_primary_10_1016_j_rmcr_2022_101597 crossref_primary_10_35366_93964 crossref_primary_10_1038_s41422_020_0369_7 crossref_primary_10_3390_jcm10112452 crossref_primary_10_1111_ctr_15482 crossref_primary_10_3390_cells11132065 crossref_primary_10_4285_kjt_2020_34_2_71 crossref_primary_10_3389_fphar_2020_577571 crossref_primary_10_3390_ijms251910578 crossref_primary_10_1016_S2213_2600_21_00077_1 crossref_primary_10_1016_j_athoracsur_2022_09_039 crossref_primary_10_12998_wjcc_v11_i30_7475 crossref_primary_10_1016_j_biopha_2021_111300 crossref_primary_10_1016_j_transproceed_2022_03_007 crossref_primary_10_1126_sciadv_ade7647 crossref_primary_10_1590_1678_4685_gmb_2020_0212 crossref_primary_10_1111_imr_12977 crossref_primary_10_1053_j_jvca_2022_11_002 crossref_primary_10_1080_07853890_2021_1875500 crossref_primary_10_1111_ajt_16411 crossref_primary_10_1016_j_tcb_2021_10_002 crossref_primary_10_1055_s_0041_1728756 crossref_primary_10_1016_S2213_2600_20_30361_1 crossref_primary_10_5500_wjt_v15_i2_99992 crossref_primary_10_1097_SLA_0000000000004514 crossref_primary_10_1007_s00430_021_00727_0 crossref_primary_10_1016_j_healun_2020_06_026 crossref_primary_10_1055_s_0042_1759568 crossref_primary_10_1053_j_semtcvs_2022_08_008 crossref_primary_10_29328_journal_jprr_1001022 crossref_primary_10_12688_f1000research_24441_2 crossref_primary_10_3390_jcm12237461 crossref_primary_10_1111_ajt_16368 crossref_primary_10_12688_f1000research_24441_1 crossref_primary_10_1007_s00104_021_01374_0 crossref_primary_10_3390_surgeries2020020 crossref_primary_10_1093_cid_ciad072 crossref_primary_10_1161_CIRCULATIONAHA_120_050754 crossref_primary_10_2139_ssrn_3997859 crossref_primary_10_1093_ofid_ofac425 crossref_primary_10_1155_2020_6175964 crossref_primary_10_3389_fimmu_2020_01392 crossref_primary_10_1177_17534666221081035 crossref_primary_10_1016_j_resmer_2021_100866 crossref_primary_10_1155_2022_7923228 crossref_primary_10_1186_s10020_020_00223_w crossref_primary_10_1186_s13098_021_00639_2 crossref_primary_10_1001_jamasurg_2023_3489 crossref_primary_10_1016_j_healun_2022_09_002 crossref_primary_10_3390_jcm11164754 crossref_primary_10_25259_DJIGIMS_20230201_39 crossref_primary_10_1016_j_apmr_2021_03_035 crossref_primary_10_1080_13880209_2021_1950192 crossref_primary_10_31482_mmsl_2022_004 crossref_primary_10_5694_mja2_50674 crossref_primary_10_1016_j_trim_2021_101395 crossref_primary_10_1097_TP_0000000000003706 crossref_primary_10_1016_j_resmer_2021_100851 crossref_primary_10_1038_s41584_021_00608_z crossref_primary_10_1016_j_eclinm_2021_100778 crossref_primary_10_1016_j_phymed_2023_154777 crossref_primary_10_1097_TP_0000000000004415 crossref_primary_10_1016_j_jtcvs_2020_11_081 crossref_primary_10_3390_jcm12124041 crossref_primary_10_1016_j_ajps_2020_06_001 crossref_primary_10_1097_MOT_0000000000000862 crossref_primary_10_1016_j_pccm_2022_12_002 crossref_primary_10_1016_j_surge_2020_07_001 crossref_primary_10_1016_S2213_2600_20_30393_3 crossref_primary_10_1590_1516_3180_2021_0842_r1_13102021 crossref_primary_10_5090_jcs_22_055 crossref_primary_10_1002_iid3_501 crossref_primary_10_1111_his_14249 crossref_primary_10_3390_biomedicines11061739 crossref_primary_10_3390_v15020533 crossref_primary_10_1111_ctr_14182 crossref_primary_10_2174_1573405617666210917125045 crossref_primary_10_1093_ajcp_aqab208 crossref_primary_10_54844_hamp_2022_0028 crossref_primary_10_1016_j_jtcvs_2020_12_011 crossref_primary_10_1183_13993003_01808_2020 crossref_primary_10_5812_iranjradiol_105747 crossref_primary_10_1016_j_peptides_2022_170848 crossref_primary_10_25259_Cytojournal_67_2020 crossref_primary_10_1080_17476348_2021_1916472 crossref_primary_10_1016_j_ebiom_2022_104351 crossref_primary_10_1016_j_xjtc_2022_01_019 crossref_primary_10_1007_s11596_024_2936_5 crossref_primary_10_1016_j_jtcvs_2020_10_154 crossref_primary_10_1038_s41467_020_19581_4 crossref_primary_10_1183_13993003_02404_2021 crossref_primary_10_58742_cgrahg12 crossref_primary_10_1097_MD_0000000000026468 crossref_primary_10_1016_j_eclinm_2020_100612 crossref_primary_10_1007_s40472_022_00362_5 crossref_primary_10_1097_TP_0000000000004151 crossref_primary_10_1080_20961790_2020_1807128 crossref_primary_10_1111_ajt_16449 crossref_primary_10_12968_jowc_2021_30_8_594 crossref_primary_10_4103_atm_atm_103_22 crossref_primary_10_1016_j_athoracsur_2021_10_004 crossref_primary_10_18632_aging_202500 crossref_primary_10_3390_ijerph19127355 crossref_primary_10_3390_biomedicines9080966 crossref_primary_10_1016_j_cmi_2022_02_005 |
| Cites_doi | 10.1016/S0140-6736(20)30566-3 10.1001/jama.2020.1585 10.21037/hbsn.2017.07.08 10.21037/atm.2019.10.26 10.1097/MAT.0000000000000450 10.1056/NEJMoa2002032 10.1016/S0140-6736(20)30183-5 10.1016/j.athoracsur.2019.02.035 |
| ContentType | Journal Article |
| Copyright | The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2020 |
| Copyright_xml | – notice: The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. – notice: Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2020 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 2B. 4A8 92I 93N PSX TCJ 5PM DOA |
| DOI | 10.1097/CM9.0000000000000839 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitle_FL | Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis |
| EISSN | 2542-5641 |
| EndPage | 1396 |
| ExternalDocumentID | oai_doaj_org_article_9de52c961f1f4cfa81cf73142ecf9810 PMC7339336 zhcmj202012029 32251003 10_1097_CM9_0000000000000839 00029330-202006200-00002 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: This study was supported by grants from the Chen Jingyu team of "Sanming Project of Medicine" in Shenzhen; This study was supported by grants from the Chen Jingyu team of "Sanming Project of Medicine" in Shenzhen funderid: (No. SZSM201812058); (No. SZSM201812058) |
| GroupedDBID | --- -05 -0E 0R~ 29B 2WC 40I 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92M AAAAV AAHPQ AAIQE AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABZZY ACGFO ACGFS ACILI ACXJB ADGGA ADHPY ADPDF AENEX AFBFQ AFDTB AFKRA AHMBA AHQNM AHVBC AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BQLVK BVXVI CCEZO CCPQU CHBEP CIEJG CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IKREB JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RLZ RNS RPM RT5 S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U5O UKHRP W2D WFFXF XSB AAYXX CITATION OVT 3V. ABXLX CGR CUY CVF ECM EIF NPM Q-- Q-4 7XB 8FK AZQEC COVID DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 -SE -S~ .55 .GJ 2B. 4A8 53G 93N 9D9 9DE ADRAZ AFUIB C1A CAJEE H13 IHW INH INR IPNFZ ITC PMFND PSX PV9 R-E RIG RZL U1G U5E X7J X7M ZGI ZXP 5PM PUEGO |
| ID | FETCH-LOGICAL-c6442-be03e5d4f66ac8201322b126f34d17df19e552a4016fb3ee3a4572b9dccfde803 |
| IEDL.DBID | DOA |
| ISSN | 0366-6999 2542-5641 |
| IngestDate | Wed Aug 27 01:21:16 EDT 2025 Thu Aug 21 18:32:49 EDT 2025 Thu May 29 03:55:41 EDT 2025 Fri Jul 11 03:07:48 EDT 2025 Fri Jul 25 23:20:27 EDT 2025 Wed Feb 19 02:29:18 EST 2025 Thu Apr 24 22:50:33 EDT 2025 Tue Jul 01 03:02:40 EDT 2025 Fri May 16 03:50:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | Acute respiratory distress syndrome Pulmonary fibrosis Coronavirus disease 2019 Sequential Organ Failure Assessment score Lung transplantation |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6442-be03e5d4f66ac8201322b126f34d17df19e552a4016fb3ee3a4572b9dccfde803 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/9de52c961f1f4cfa81cf73142ecf9810 |
| PMID | 32251003 |
| PQID | 2480933474 |
| PQPubID | 2042885 |
| PageCount | 7 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9de52c961f1f4cfa81cf73142ecf9810 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7339336 wanfang_journals_zhcmj202012029 proquest_miscellaneous_2387253747 proquest_journals_2480933474 pubmed_primary_32251003 crossref_primary_10_1097_CM9_0000000000000839 crossref_citationtrail_10_1097_CM9_0000000000000839 wolterskluwer_health_00029330-202006200-00002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-06-20 |
| PublicationDateYYYYMMDD | 2020-06-20 |
| PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China – name: Baltimore |
| PublicationTitle | Chinese medical journal |
| PublicationTitleAlternate | Chin Med J (Engl) |
| PublicationTitle_FL | Chinese Medical Journal |
| PublicationYear | 2020 |
| Publisher | The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license Lippincott Williams & Wilkins Ovid Technologies Wuxi Lung Transplant Center, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Thoracic Surgery, Shenzhen Third People’s Hospital, Shenzhen, Guangdong 518100, China%Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China%Department of Cardiothoracic Surgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China%Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China%Department of Respiratory Medicine and Critical Care Medicine, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China%Department of Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Anesthesiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China Wolters Kluwer Health Wolters Kluwer |
| Publisher_xml | – name: The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license – name: Lippincott Williams & Wilkins Ovid Technologies – name: Wuxi Lung Transplant Center, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Thoracic Surgery, Shenzhen Third People’s Hospital, Shenzhen, Guangdong 518100, China%Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China%Department of Cardiothoracic Surgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China%Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China%Department of Respiratory Medicine and Critical Care Medicine, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China%Department of Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Anesthesiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China – name: Wolters Kluwer Health – name: Wolters Kluwer |
| References | Salam (R12-20230816) 2017; 63 Huang (R14-20230816) 2020; 395 Huang (R5-20230816) 2017; 6 Wang (R10-20230816) 2019; 108 Luo (R9-20230816) 2020 Zhou (R7-20230816) 2020; 395 Wu (R13-20230816) 2020; 8 Chang (R11-20230816) 2018; 102 Cucinotta (R2-20230816) 2020; 91 Wang (R4-20230816) 2020 Guan (R3-20230816) 2020 (R8-20230816) 2020 Chen (R6-20230816) 2018; 9 32718694 - J Heart Lung Transplant. 2020 Sep;39(9):983-985 32631838 - Eur Respir J. 2020 Aug 27;56(2) |
| References_xml | – volume: 395 start-page: 1054 year: 2020 ident: R7-20230816 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)30566-3 – start-page: 133 year: 2020 ident: R8-20230816 article-title: Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7) publication-title: Chin Med J – year: 2020 ident: R4-20230816 article-title: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China publication-title: JAMA doi: 10.1001/jama.2020.1585 – volume: 6 start-page: 212 year: 2017 ident: R5-20230816 article-title: The “Chinese Mode” of organ donation and transplantation publication-title: Hepatobiliary Surg Nutr doi: 10.21037/hbsn.2017.07.08 – volume: 8 start-page: 41 year: 2020 ident: R13-20230816 article-title: China lung transplantation developing: past, present and future publication-title: Ann Transl Med doi: 10.21037/atm.2019.10.26 – volume: 102 start-page: 829 year: 2018 ident: R11-20230816 article-title: Lung transplantation as a therapeutic option in acute respiratory distress syndrome publication-title: Transplantation 2018; – volume: 9 start-page: 325 year: 2018 ident: R6-20230816 article-title: Chinese lung donation standard and procurement guidelines (In Chinese) publication-title: Organ Transplantation – volume: 63 start-page: e66 year: 2017 ident: R12-20230816 article-title: Lung transplantation after 125 days on ECMO for severe refractory hypoxemia with no prior lung disease publication-title: ASAIO J doi: 10.1097/MAT.0000000000000450 – year: 2020 ident: R3-20230816 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N Engl J Med doi: 10.1056/NEJMoa2002032 – volume: 91 start-page: 157 year: 2020 ident: R2-20230816 article-title: WHO declares COVID-19 a pandemic publication-title: Acta Biomed – volume: 395 start-page: 497 year: 2020 ident: R14-20230816 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – start-page: 2020020407 year: 2020 ident: R9-20230816 article-title: Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19) publication-title: Preprints – volume: 108 start-page: e233 year: 2019 ident: R10-20230816 article-title: Lung transplantation in pulmonary fibrosis secondary to influenza A pneumonia publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2019.02.035 – reference: 32631838 - Eur Respir J. 2020 Aug 27;56(2): – reference: 32718694 - J Heart Lung Transplant. 2020 Sep;39(9):983-985 |
| SSID | ssj0025576 ssib001521049 ssib051457378 ssib044732928 ssib008142972 ssib038074633 ssib017628699 ssib058574914 ssib020751800 ssib001103466 ssib022315857 ssib000827134 ssib006703066 ssib058492515 ssib051368197 |
| Score | 2.5857825 |
| Snippet | Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal... BackgroundCritical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving... Background::Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving... Background. Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving... |
| SourceID | doaj pubmedcentral wanfang proquest pubmed crossref wolterskluwer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1390 |
| SubjectTerms | Aged Betacoronavirus Blood & organ donations Coronary vessels Coronavirus Infections - complications Coronavirus Infections - mortality Coronaviruses COVID-19 Disease transmission Extracorporeal Membrane Oxygenation Heart Hospitals Humans Lung Transplantation - methods Lung transplants Male Medical personnel Middle Aged Original Pandemics Patients Pneumonia, Viral - complications Pneumonia, Viral - mortality Pulmonary fibrosis Pulmonary Fibrosis - mortality Pulmonary Fibrosis - surgery Rehabilitation Respiratory distress syndrome Respiratory Distress Syndrome - mortality Respiratory Distress Syndrome - surgery Respiratory failure SARS-CoV-2 |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELZgEYgL4k1gASNxjTZ-xI5PCFasVohyYqXeIsexd7uUpDQtK_EP-NfMJE4fgCCHHmIncT3j8Yxn5htCXldBBJ8ZmzLNwEABqzYtlAyprmTN8iAKZ_G8Y_JJnZ7JD9N8Gg_cuhhWOcrEXlDXrcMz8iMuCzS-pZZvFt9SrBqF3tVYQuM6uYHQZRjSpadbgyvPdfRVqlSBJjSmzhl9dDwxA3TheBVYLnxna-oR_P-mdv4ZPXnzyjbBNufQctWij7v70oe472xUJ3fJnahh0rcDS9wj13xzn9yaRB_6A_LzI6xvuupBzed2yDxqqO3oTioWbXtJQmfQ4NYrT5dbjzytZ0OCCR3RDigovtQhFIL9PluuOxq9PhS2fZP22TK-pov1HObQwgsCmOhtN-sekrOT95-PT9NYkCF1oDbxtPKZ8Hktg1LWoeoA0qBiXAUBhNV1YMbnObdgsqlQCe-FlbnmlamdC7UvMvGIHDRt458QCmLVgWppghUO3sdtFqSsFXCNMJlyVULESIvSRbRyLJoxL0evOVCw_J2CCUk3Ty0GtI7_9H-HZN70Razt_ka7PC_j0i1N7XPujGKBBemCLZgLWjDJvQumYFlCDkcmKaMA6Motuybk1aYZli76Y2zj2zX0EYXmuQCDLiGPB57ajATlLAOJmxC9x217Q91vaWYXPTy4FgK-rBLyMvLldlQ_LtzXSw4WAoMfnK09fi2H1FucJY7nXCn2zBQfsAcy_vTff_QZuY0PYBwdzw7JwWq59s9BY1tVL_pl-QvxtTyg priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKEYgL4k2ggJG4GsWP2PEBIaioKsRyYqXeIsex28CStMluC_wD_jXjvNpAERf2kMPacSzPjP2Nx_MZoRe5597F2hCqKDgo4NWSVApPVC4KmnieWhP2OxYf5f5SvD9IDrbQeGfrMIDtpa5duE9q2axefjv5_hoM_tVIwLi70D0N4fiDRf8KugprkwqmuhBTXAHwsxqil5JIwEZjMt1fWpktVh2n_2VA9M_zlNfOTOVNdQglZ3WIerdfukPvF5auvVvo5oA58ZteSW6jLVfdQdcXQ1T9Lvr5ASwerzua85Xpc5EqbFp8ITkL193cgksosJu1w815jB4XZZ9ygkf-AwxQGNtAjmBOy2bT4iEOhAEIaNLlz7gCH29WYAQGGvDgtNdt2d5Dy713n3b3yXBFA7EApBjJXcxdUggvpbEBTMD8kFMmPQdRq8JT7ZKEGXDipM-5c9yIRLFcF9b6wqUxv4-2q7pyDxGGidYC2NTecAvtMRN7IQoJesR1LG0eIT7KIrMDf3m4RmOVjXF0kGD2uwQjRKa3jnv-jn_UfxvEPNUN7NvdH3VzmA3GnOnCJcxqST31wnqTUusVp4I563VK4wjtjEqSjRqdMZGG3SOhRISeT8VgzCFCYypXb6AOTxVLOLh4EXrQ69TUkzDzUpiDI6Rm2jbr6rykKo86wnDFOXxZRujZoJfnvfpxZL9-ZuAzUHiE0Zrpa9Yn44ZRYmHni4SasWQ9G0HMHv2P0XqMboRmw_k7Fu-g7XWzcU8A6a3zp53x_gLbkk1Q priority: 102 providerName: Scholars Portal |
| Title | Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-202006200-00002 https://www.ncbi.nlm.nih.gov/pubmed/32251003 https://www.proquest.com/docview/2480933474 https://www.proquest.com/docview/2387253747 https://d.wanfangdata.com.cn/periodical/zhcmj202012029 https://pubmed.ncbi.nlm.nih.gov/PMC7339336 https://doaj.org/article/9de52c961f1f4cfa81cf73142ecf9810 |
| Volume | 133 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCNQL4t1AWYzENWr8jo-0aqkQWyFEpb1FjmPThSWpNhsq8Q_414zjZLsLSL2wBx_WjuN4PtszHs9nhN6UnnmXaZMSRcBAAas2zSX3qSp5RYRnuTVhv2N6Jk_P-fuZmG1c9RXOhEV64NhxB7pyglotiSeeW29yYr1ihFNnvc5jcBWseaMxNZhaQqjBSylTCTrQGDSn1cHRVEfSwvGXh4vCNxalnrv_Xwrn3-cm716Z2pv6C-RcNcG73X7rD7dvLFEnD9D9QbfEb-M3PUS3XP0I3ZsO3vPH6NcHGNl41dOZL0yMOaqxafFGEBZu-jkEzyHDdiuHl9e-eFzNY2gJHnkOMKi82AYSBPNjvuxaPPh7MCz4Ou3jZFyFL7sFgN1ABR6M86adt0_Q-cnx56PTdLiKIbWgMNG0dBlzouJeSmOD0gDzQEmo9AxEqipPtBOCGjDWpC-Zc8xwoWipK2t95fKMPUU7dVO7PYRhQrWgVGpvmIX6qMk855UEvDCdSVsmiI2yKOzAUx6uy1gUo78cJFj8KcEEpeunLiNPxw3lD4OY12UDy3b_B2CvGLBX3IS9BO2PICmGod8WlOdhl4grnqDX62wYtMETY2rXdFCG5YoKBqZcgp5FTK1bEmZYAnNtgtQW2raaup1Tzy96YnDFGLxZJujVgMvrVv28sN-_UrANCCSht7bwWsSg29BLNOxwpaFkJmlkHcjo8__RWy_Qbqg2nLOj2T7aWS079xI0ulU5QbfVTE3QncPjs4-fJv1QhvTdjEA65flv6wZJ7Q |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLbKVCwXxE6gUCPB0Wq8xEkOCNHSakpnKoRaqbfgOHYbGJJhMsMI_gF_ht_Ic5ZZAMGpOcwhdhyP38vn9_w2hJ6nllvjx4rQkIKCAlotiaSwJExFRgPLI63cecfwWPZPxduz4GwD_exiYZxbZYeJNVBnpXZn5DtMRE75FqF4Nf5CXNUoZ13tSmg0bHFkvs1BZateHr4B-r5g7GD_ZK9P2qoCRMPez0hqfG6CTFgplXb7H7B0Spm0HGYXZpbGJgiYAr1D2pQbw5UIQpbGmdY2M5HPYdwraFNwUGV6aHN3__jd-4WKFwRhax2VRILs1QXrxeHO3jBukiV2V-QKlK9shnXNgL8Jun_6a16dq8Kq4hxa5qWzqlefaqf6la3x4Ba62cq0-HXDhLfRhinuoGvD1mp_F_0YAKLgaZ1GfaSaWKcCqwqvBH_hssYunEODnk0Nnix9AHCWNyEtuMuvgEHUxtolX1Bf88mswq2dCcNCx6SOzzEZHs9GQDUFA9g8hQXIq3vo9FKIdR_1irIwDxEGINcgzMZWcQ3jMeVbITIJfMpjX-rUQ7yjRaLb_OiuTMco6ez0QMHkdwp6iCyeGjf5Qf7Tf9eRedHXZfeub5ST86QFiyTOTMB0LKmlVmirIqptyKlgRts4or6HtjomSVrIqZLlB-KhZ4tmAAtnAVKFKWfQh0chCziokB560PDUYiYO2SlgvIfCNW5bm-p6S5Ff1AnJQ87hzdJD2y1fLmf1_UJ__shAJ6Hw41ZrjV-TJtjXrRJzJ2vE9fQla7Id-OzRv__oNrrePxkOksHh8dFjdMM97Lz4mL-FetPJzDwBeXGaPm0_Uow-XDYu_ALLQHq7 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJyZeEN8EBjMSyltQYjtO8pCH0Q_GWLtJ3WB7ihzH3golqZp2E_wH_Nec89GtfAjRh7bqXVwrvrvc-e5-Ruh1qqlWbiQcL_AgQIGo1gk5006QsszzNQ2lMPsdwxHfO2H7p_7pBmpLh0zzWTl7Yz4qM22-mONwTFx4HO-P7e64G5_Zo_6ncTyyj3bf9attalMkYR_1BvE3uxcXl3ph9w7jFp-xO4xqlML2BT7BLbQZhtxlHbR5-LHf761iNN8PmvQmdzg4T2233V_GWXuaVaD_f_JUfy-4vH0lci3yc6BcFSYtXn6pquJvPNsG99DdxinFu7UU3UcbKn-AtoZN2v0h-nEAJgEvKhz0qaiblXIsSnyjewsXlfHBEyDI5ULh-XUSH2eTuicFtwAJGHxlLA16griczJclbhJFGDyFyKkabFSGZ8spaImAATRE9UU5KR-hk0H_uLvnNGc4OBI8LeKkyqXKz5jmXEjjbYABST3CNQVZCDLtRcr3iYAoj-uUKkUF8wOSRpmUOlOhSx-jTl7k6inCYIkleKORFlTCeES4mrGMg6DRyOUytRBt1yKRDcC5OWdjmrSJdljB5NcVtJCzumpWA3z8g_-tWeYVr4Hnrn4o5udJo-1JlCmfyIh72tNMahF6UgfUY0RJHYWea6HtVkiSxmaUCWGh2V5iAbPQqxUZtN2kcESuiiXw0DAgPoUY0EJPaplazcSYZg-MtIWCNWlbm-o6JZ9cVIjiAaXwz9xCO41cXs_q-4X8-plAUOHBm7lba_Ka1N265i4RszXmGE6XkxquwCXP_pN_B22BGicH70cfnqM7hmjK8oi7jTqL-VK9AAdwkb5slPYnyclPog |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+transplantation+as+therapeutic+option+in+acute+respiratory+distress+syndrome+for+coronavirus+disease+2019-related+pulmonary+fibrosis&rft.jtitle=Chinese+medical+journal&rft.au=Jing-Yu+Chen&rft.au=Kun+Qiao&rft.au=Feng+Liu&rft.au=Bo+Wu&rft.date=2020-06-20&rft.pub=Wolters+Kluwer&rft.issn=0366-6999&rft.eissn=2542-5641&rft.volume=133&rft.issue=12&rft.spage=1390&rft.epage=1396&rft_id=info:doi/10.1097%2FCM9.0000000000000839&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_9de52c961f1f4cfa81cf73142ecf9810 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg |